step one ventures tirzepatide Lilly releases Zepbound® (tirzepatide) single-dose vials, expanding supply and access for adults living with obesity COMPOUNDED TIRZEPATIDE

One of the more interesting things buried inside the Medicare GLP-1 Bridge Program prior authorization form is what it tells us about who this program is actually designed to help

Essential guidance for patients starting semaglutide tablets for type 2 diabetes.

By harnessing the bodys natural hormonal pathways, Tirzepatide provides a refined solution for individuals seeking sustainable weight loss and improved overall well-being

Emerging research suggests GLP-1 drugs like Ozempic, Wegovy, and Mounjaro may help reduce alcohol and substance cravings, offering a potential new treatment for addiction.

Lilly is testing whether tirzepatide can move beyond weight loss and become part of an immunometabolism strategy for chronic immune-inflammatory diseases.

As a dual GIP/GLP-1 receptor agonist, Tirzepatide may help increase insulin sensitivity, reduce body fat, stabilize glucose levels